FNY Partners Fund’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

FNY Partners Fund’s Portfolio NDRM Stock Details NDRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-700	Closed	-$27K	–	743
2017 Q3	$27K	Buy	+700	New	+$25.8K	﹤0.01%	352
2017 Q2	–	Sell	-2,500	Closed	-$66K	–	1549
2017 Q1	$66K	Buy	+2,500	New	+$61.9K	0.01%	636

Other funds holding NDRM

VOAM

Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

FNY Partners Fund's NDRM Position: Q4 2017 in Review

FNY Partners Fund sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 700 shares — an estimated $27K sold.

FNY Partners Fund first reported a position in NDRM in Q1 2017 and held it in 2 quarters. The position peaked at $66K in Q1 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

FNY Partners Fund reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
FNY Partners Fund sold 700 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $27K.
FNY Partners Fund first reported a position in NeuroDerm Ltd. Ordinary Shares in Q1 2017 and held it in 2 quarters.
FNY Partners Fund's NeuroDerm Ltd. Ordinary Shares position peaked at $66K in Q1 2017.
5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on FNY Partners Fund's 13F filing for Q4 2017, filed 24 Jan 2018.